Luczkowski Marek, De Ricco Riccardo, Stachura Monika, Potocki Slawomir, Hemmingsen Lars, Valensin Daniela
Faculty of Chemistry, University of Wroclaw, F. Joliot Curie 14, 50-383 Wroclaw, Poland.
Metallomics. 2015 Mar;7(3):478-90. doi: 10.1039/c4mt00274a.
Furin-dependent maturation of the BRI2 protein generates the Bri2-23 fragment that is able to arrest the aggregation of amyloidβ, the peptide implicated in Alzheimer's disease (AD). Bri2-23 contains cysteines at positions 5 and 22, which are likely to bind to metal ions such as Cu(i). Metal ions may play a role in the etiology of neurodegenerative disorders such as AD, and in this work we explore the metal ion induced folding and aggregation of Bri2-23 using Hg(ii) and Ag(i) as spectroscopic probes with structural and ligand preferences similar to those of Cu(i), while not displaying redox activity under the experimental conditions. In general, interaction of Bri2-23 with soft metal ions changes the structural properties and solution behavior of the peptide that tune to increasing metal to peptide stoichiometry. Potentiometric, (199m)Hg PAC and ESI-MS data indicate that addition of up to 0.5 equivalents of Hg(ii) to Bri2-23 yields a two-coordinated HgS2 structure at the metal site. While the free peptide is inherently unstructured, the presence of Ag(i) and Hg(ii) gives rise to β-sheet formation. NMR spectroscopy supports the formation of β-sheet structure in the presence of 0.5 equivalents of Hg(ii), and displays an interesting and marked change in the TOCSY spectra when increasing the Hg(ii) to peptide stoichiometry from 0.5 to 0.7 equivalents, indicating the equilibrium between two structural analogues of the complex. Addition of more than 0.7 equivalents of Hg(ii) gives rise to line broadening, presumably reflecting aggregation. This is further supported by ThT fluorescence studies showing that the Bri2-23 peptide does not aggregate over 24 hours, while addition of over 0.7 equivalents of Ag(i) or Hg(ii) leads to increase of fluorescence, indicating that these metal ions induce aggregation. Thus, a model integrating all data into a coherent picture is that the metal ion binding to the two thiolates gives rise to folding of the peptide into a structure that is prone to aggregation, forming aggregates with a considerable amount of β-sheets. Molecular dynamics simulations initiated with structures that agree with NMR data additionally support this model.
弗林蛋白酶依赖的BRI2蛋白成熟过程产生了Bri2-23片段,该片段能够抑制淀粉样β蛋白的聚集,而淀粉样β蛋白与阿尔茨海默病(AD)有关。Bri2-23在第5位和第22位含有半胱氨酸,它们可能与诸如Cu(i)等金属离子结合。金属离子可能在诸如AD等神经退行性疾病的病因中起作用,在这项工作中,我们使用Hg(ii)和Ag(i)作为光谱探针来探索金属离子诱导的Bri2-23的折叠和聚集,Hg(ii)和Ag(i)具有与Cu(i)相似的结构和配体偏好,同时在实验条件下不显示氧化还原活性。一般来说,Bri2-23与软金属离子的相互作用会改变肽的结构性质和溶液行为,这些性质会随着金属与肽化学计量比的增加而调整。电位滴定、(199m)Hg PAC和ESI-MS数据表明,向Bri2-23中加入高达0.5当量的Hg(ii)会在金属位点产生一种双配位的HgS2结构。虽然游离肽本身是无结构的,但Ag(i)和Hg(ii)的存在会导致β-折叠的形成。核磁共振光谱支持在存在0.5当量Hg(ii)的情况下形成β-折叠结构,并且当Hg(ii)与肽的化学计量比从0.5增加到0.7当量时,TOCSY光谱显示出有趣且显著的变化,表明该复合物的两种结构类似物之间的平衡。加入超过0.7当量的Hg(ii)会导致谱线变宽,推测这反映了聚集。硫黄素T荧光研究进一步支持了这一点,该研究表明Bri2-23肽在24小时内不会聚集,而加入超过0.7当量的Ag(i)或Hg(ii)会导致荧光增加,表明这些金属离子诱导聚集。因此,一个将所有数据整合为连贯图景的模型是,金属离子与两个硫醇盐结合会导致肽折叠成易于聚集的结构,形成具有大量β-折叠的聚集体。从与核磁共振数据一致的结构开始的分子动力学模拟进一步支持了该模型。